Approaches to sample size estimation in the design of clinical trials--a review.
about
Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertensionEvaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.Age and gender dependent bioavailability of R- and R,S-α-lipoic acid: a pilot study.Clinical research: the pharmaceutical industry's point of viewGastric tonometry guided therapy in critical care patients: a systematic review and meta-analysisRisk factors for recurrent bile duct stones after endoscopic papillotomyProtocol for the Northern Manhattan Diabetes Community Outreach Project. A randomised trial of a community health worker intervention to improve diabetes care in Hispanic adultsSample size estimation and power analysis for clinical research studies.Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial.Basic design considerations for clinical trials in oncology.Vitrectomy with or without encircling band for pseudophakic retinal detachment: a multi-centre, three-arm, randomised clinical trial. VIPER Study Report No. 1--design and enrolmentDisciplined analyses in clinical trials: the dark heart of the matter.Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens.Protocol for assessing the hypotensive effect of evening administration of acetylsalicylic acid: study protocol for a randomized, cross-over controlled trial.Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.Practical sample size calculations for surveillance and diagnostic investigations.Endometriosis fertility index score maybe more accurate for predicting the outcomes of in vitro fertilisation than r-AFS classification in women with endometriosis.Some basic aspects of statistical methods and sample size determination in health science researchSample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.Sample size calculation of clinical trials published in two leading endodontic journals.Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.Confidence intervals and sample sizes: don't throw out all your old sample size tables.Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons.Adverse outcomes and opioid analgesic administration in acute abdominal pain.Study of the Atopic March: Development of Atopic Comorbidities.A multi-center, randomized, controlled trial to assess the efficacy of optimization of drug prescribing in an elderly population, at 18 months of follow-up, in the evolution of functional autonomy: the OPTIM study protocol.Sample size and robust marginal methods for cluster-randomized trials with censored event times.Misoprostol for abortion at 9-12 weeks' gestation in adolescents.Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST).Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study.The design of phase III palliative chemotherapy trials in head and neck cancer.Sample size calculations with compliance information.Treatment of elderly patients with delirium.Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).Sample size determination for clinical trials in patients with nonlinear disease progression.Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.Incorporating cost in power analysis for three-level cluster-randomized designs.
P2860
Q28377575-A8A5EC52-B758-4516-A5E9-EA7167FE7557Q33317432-DF59EE50-8847-4CBC-BCAF-1928E2FDB0E4Q33854686-EE8247B0-30BB-4967-B649-DD47AF09096EQ34137737-ECDA2E3E-4E5C-4635-9900-4A03A0968D4FQ35549429-12E655F7-1F05-4277-BC43-0398C7178D28Q35595372-BC978380-AF6F-4A87-A069-47F7414EEE66Q35899448-C4D048D1-DB9C-40A1-AEA0-DDC5F8437486Q36133436-32E0BED9-5ABE-406D-B383-81B8F767FAFCQ36233895-332A0334-80DE-4086-8A84-C4403C3AC565Q36381909-C9C4811D-011A-4CCF-AA48-A50FCF55ECB9Q36681934-092B97B6-B14A-4477-AA75-94289FD515D5Q36966434-CA4C6D07-F99A-4118-962C-3BDB7EFA315BQ37045362-C5023626-146D-475A-8FDD-434C4DCA578DQ37113359-CDB47E3E-4BA0-4986-AB92-97A92BB62E70Q37274726-948FFC1C-1F30-410B-8550-7B36BDE78D62Q37367195-E8346188-5843-401B-AD73-D359FCEDAA57Q37400937-D9EE9094-9459-45EF-BF4D-451DC73B5896Q38307103-EE18F4FD-7D05-4606-A702-58B10B39F159Q38945580-6B41C161-5D77-4850-BCFD-405AF61FBBF2Q39278447-FD3B73FF-0F97-4193-A186-DF3E689D5991Q39422116-7515CA10-0ACA-4E2D-9504-5F05763DCE4BQ39440440-08BAAADD-4ADF-40A0-8EAC-9E458B3F7032Q39442247-C64E2D2B-42A9-4441-9632-9A57FF777297Q40078124-DF142CBE-CC1D-49F7-8687-C5EE441B5C9EQ40426249-B6A30AF2-0869-498F-A1C7-6492E114233BQ40613146-4B21BE4F-933A-4A78-A0EE-0A475A3ECCEDQ40713406-C52FEC0A-08B8-4D72-A7ED-EE1159AD3F3EQ41570536-D5D7C845-CC4E-4EE7-B844-23E46D2774E5Q41672954-27D5409B-16AE-4D4A-9406-D9EB857853C8Q43596075-49EA8023-ED83-41D9-A5C4-153FEEACEE5EQ43604157-584701FE-64C2-4395-960D-92E1A11915DBQ43996918-3738619C-951F-4C5D-93E6-1BE2FCFA2FF5Q44112212-2212A905-D821-4340-A92E-58F6D46AF242Q44375766-5D5198BE-21D7-4546-A0A4-A170D0FD1CB6Q44504562-48015E8F-AD6C-4C0C-9DA2-E4C08E9E4B86Q45338729-56A90A73-C39F-4917-B618-FCD5BB1D3A50Q47253208-7A64D53C-0E1D-4E83-ACC1-3FB9661C7CF5Q47351779-4034451E-8828-4182-B91B-ED2605BB477DQ47677542-066AB0A4-0F57-4944-8336-52D5647AD7DBQ51822622-919648AD-39E4-4F3B-9281-A6B129626664
P2860
Approaches to sample size estimation in the design of clinical trials--a review.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Approaches to sample size estimation in the design of clinical trials--a review.
@en
type
label
Approaches to sample size estimation in the design of clinical trials--a review.
@en
prefLabel
Approaches to sample size estimation in the design of clinical trials--a review.
@en
P356
P1476
Approaches to sample size estimation in the design of clinical trials--a review.
@en
P2093
P304
P356
10.1002/SIM.4780030302
P407
P577
1984-07-01T00:00:00Z